Gil M Labrucherie - Net Worth and Insider Trading
Gil M Labrucherie Net Worth
The estimated net worth of Gil M Labrucherie is at least $820,965 dollars as of 2024-05-15. Gil M Labrucherie is the SVP, COO & CFO of Nektar Therapeutics and owns about 312,905 shares of Nektar Therapeutics (NKTR) stock worth over $553,842. Gil M Labrucherie is also the Director of Rezolute Inc and owns about 99,673 shares of Rezolute Inc (RZLT) stock worth over $267,124. Details can be seen in Gil M Labrucherie's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Gil M Labrucherie has not made any transactions after 2022-05-16 and currently still holds the listed stock(s).
Transaction Summary of Gil M Labrucherie
Gil M Labrucherie Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Gil M Labrucherie owns 3 companies in total, including Nektar Therapeutics (NKTR) , Rezolute Inc (RZLT) , and Acelyrin Inc (SLRN) .
Click here to see the complete history of Gil M Labrucherie’s form 4 insider trades.
Insider Ownership Summary of Gil M Labrucherie
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| NKTR | Nektar Therapeutics | 2022-05-16 | SVP & COO & CFO |
| RZLT | Rezolute Inc | 2022-05-04 | director |
| SLRN | Acelyrin Inc | 2023-08-02 | Interim CFO |
Gil M Labrucherie Latest Holdings Summary
Gil M Labrucherie currently owns a total of 2 stocks. Among these stocks, Gil M Labrucherie owns 312,905 shares of Nektar Therapeutics (NKTR) as of May 16, 2022, with a value of $553,842 and a weighting of 67.46%. Gil M Labrucherie also owns 99,673 shares of Rezolute Inc (RZLT) as of May 4, 2022, with a value of $267,124 and a weighting of 32.54%.
Latest Holdings of Gil M Labrucherie
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| NKTR | Nektar Therapeutics | 2022-05-16 | 312,905 | 1.77 | 553,842 |
| RZLT | Rezolute Inc | 2022-05-04 | 99,673 | 2.68 | 267,124 |
Holding Weightings of Gil M Labrucherie
Gil M Labrucherie Form 4 Trading Tracker
According to the SEC Form 4 filings, Gil M Labrucherie has made a total of 20 transactions in Nektar Therapeutics (NKTR) over the past 5 years, including 0 buys and 20 sells. The most-recent trade in Nektar Therapeutics is the sale of 17,448 shares on May 16, 2022, which brought Gil M Labrucherie around $68,920.
According to the SEC Form 4 filings, Gil M Labrucherie has made a total of 2 transactions in Rezolute Inc (RZLT) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Rezolute Inc is the acquisition of 52,631 shares on May 4, 2022, which cost Gil M Labrucherie around $199,998.
Insider Trading History of Gil M Labrucherie
- 1
Gil M Labrucherie Trading Performance
GuruFocus tracks the stock performance after each of Gil M Labrucherie's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Gil M Labrucherie is -15.12%. GuruFocus also compares Gil M Labrucherie's trading performance to market benchmark return within the same time period. The performance of stocks bought by Gil M Labrucherie within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Gil M Labrucherie's insider trading performs compared to the benchmark.
Performance of Gil M Labrucherie
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -25.2 | | | | | |
| Relative Return to S&P 500(%) | -20.74 | | | | | |
Gil M Labrucherie Ownership Network
Gil M Labrucherie Owned Company Details
What does Nektar Therapeutics do?
Who are the key executives at Nektar Therapeutics?
Gil M Labrucherie is the SVP & COO & CFO of Nektar Therapeutics. Other key executives at Nektar Therapeutics include SVP & General Counsel Mark Andrew Wilson , Chief R&D Officer Jonathan Zalevsky , and director & President & CEO Howard W Robin .
Nektar Therapeutics (NKTR) Insider Trades Summary
Over the past 18 months, Gil M Labrucherie made no insider transaction in Nektar Therapeutics (NKTR). Other recent insider transactions involving Nektar Therapeutics (NKTR) include a net sale of 137,918 shares made by Howard W Robin , a net sale of 62,098 shares made by Jonathan Zalevsky , and a net sale of 46,514 shares made by Mark Andrew Wilson .
In summary, during the past 3 months, insiders sold 92,653 shares of Nektar Therapeutics (NKTR) in total and bought 0 shares, with a net sale of 92,653 shares. During the past 18 months, 332,610 shares of Nektar Therapeutics (NKTR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 332,610 shares.
Nektar Therapeutics (NKTR)'s detailed insider trading history can be found in Insider Trading Tracker table.
Nektar Therapeutics Insider Transactions
Gil M Labrucherie Mailing Address
Above is the net worth, insider trading, and ownership report for Gil M Labrucherie. You might contact Gil M Labrucherie via mailing address: 150 Industrial Road, San Carlos Ca 94070.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
